Search results
Results From The WOW.Com Content Network
Henrietta Lacks (born Loretta Pleasant; August 1, 1920 – October 4, 1951) [2] was an African-American woman [5] whose cancer cells are the source of the HeLa cell line, the first immortalized human cell line [B] and one of the most important cell lines in medical research. An immortalized cell line reproduces indefinitely under specific ...
HeLa cells have been used to study expression of the papillomavirus E2 and apoptosis. [34] HeLa cells have also been used to study the ability of the canine distemper virus to induce apoptosis in cancer cell lines, [35] which could play an important role in developing treatments for tumor cells resistant to radiation and chemotherapy. [35]
As a cancer researcher who uses HeLa cells in my everyday work, even I sometimes find it hard to believe. ... On Aug. 1, 2023, over 70 years after doctors took Lacks’ cells without her consent ...
The book is about Henrietta Lacks and the immortal cell line, known as HeLa, that came from Lacks's cervical cancer cells in 1951. Skloot became interested in Lacks after a biology teacher referenced her but knew little about her. Skloot began conducting extensive research on her and worked with Lacks' family to create the book.
Even though she died 70 years ago her cells are still being used in medical reserach. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ...
HeLa cells went on to become a cornerstone of modern medicine, enabling countless scientific and medical innovations, including the development of the polio vaccine, genetic mapping and even COVID ...
Henrietta Lacks (born Loretta Pleasant; August 1, 1920 – October 4, 1951) was an African-American woman whose cancer cells are the source of the HeLa cell line, the first immortalized human cell line and one of the most important cell lines in medical research. An immortalized cell line reproduces indefinitely under specific conditions, and ...
The estate of Henrietta Lacks filed a lawsuit in Maryland federal court on Thursday accusing biopharmaceutical company Ultragenyx Pharmaceutical of unlawfully profiting from cells that were taken ...